Literature DB >> 2553749

Transformation of NIH 3T3 cells with basic fibroblast growth factor or the hst/K-fgf oncogene causes downregulation of the fibroblast growth factor receptor: reversal of morphological transformation and restoration of receptor number by suramin.

D Moscatelli1, N Quarto.   

Abstract

When NIH 3T3 cells were transfected with the cDNA for basic fibroblast growth factor (bFGF), most cells displayed a transformed phenotype. Acquisition of a transformed phenotype was correlated with the expression of high levels of bFGF (Quarto et al., 1989). Cells that had been transformed as a result of transfection with bFGF cDNA had a decreased capacity to bind 125I-bFGF to high affinity receptors. NIH 3T3 cells transfected with bFGF cDNA that expressed lower levels of bFGF were not transformed and had a normal number of bFGF receptors. NIH 3T3 cells transfected with the hst/Kfgf oncogene, which encodes a secreted molecule with 45% homology to bFGF, also displayed a transformed phenotype and decreased numbers of bFGF receptors. However, NIH 3T3 cells transfected with the H-ras oncogene were transformed but had a normal number of bFGF receptors. Thus, transformation by bFGF-like molecules resulted in downregulation of bFGF receptors. Receptor number was not affected by cell density for both parental NIH 3T3 cells and transformed cells. In the cells transfected with bFGF cDNA that were not transformed, the receptors could be downregulated in response to exogenous bFGF. Conditioned medium from transformed transfected cells contained sufficient quantities of bFGF to downregulate bFGF receptors on parental NIH 3T3 cells. Thus, the downregulation of bFGF receptors seemed related to the presence of bFGF in an extracytoplasmic compartment. Treatment of the transformed transfected NIH 3T3 cells with suramin, which blocks the interaction of bFGF with its receptor, reversed the morphological transformation and restored receptors almost to normal numbers. These results demonstrate that in these cells bFGF transforms cells by interacting with its receptor and that bFGF and hst/K-fgf may use the same receptor.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2553749      PMCID: PMC2115849          DOI: 10.1083/jcb.109.5.2519

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  42 in total

Review 1.  Structural characterization and biological functions of fibroblast growth factor.

Authors:  D Gospodarowicz; N Ferrara; L Schweigerer; G Neufeld
Journal:  Endocr Rev       Date:  1987-05       Impact factor: 19.871

2.  Potential oncogene product related to growth factors.

Authors:  C Dickson; G Peters
Journal:  Nature       Date:  1987 Apr 30-May 6       Impact factor: 49.962

3.  Synthesis of membrane-bound colony-stimulating factor 1 (CSF-1) and downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes.

Authors:  C W Rettenmier; M F Roussel; R A Ashmun; P Ralph; K Price; C J Sherr
Journal:  Mol Cell Biol       Date:  1987-07       Impact factor: 4.272

4.  High and low affinity binding sites for basic fibroblast growth factor on cultured cells: absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells.

Authors:  D Moscatelli
Journal:  J Cell Physiol       Date:  1987-04       Impact factor: 6.384

5.  Heparin modulation of the neurotropic effects of acidic and basic fibroblast growth factors and nerve growth factor on PC12 cells.

Authors:  G Neufeld; D Gospodarowicz; L Dodge; D K Fujii
Journal:  J Cell Physiol       Date:  1987-04       Impact factor: 6.384

6.  Purification from a human hepatoma cell line of a basic fibroblast growth factor-like molecule that stimulates capillary endothelial cell plasminogen activator production, DNA synthesis, and migration.

Authors:  M Presta; D Moscatelli; J Joseph-Silverstein; D B Rifkin
Journal:  Mol Cell Biol       Date:  1986-11       Impact factor: 4.272

7.  Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin.

Authors:  C Betsholtz; A Johnsson; C H Heldin; B Westermark
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

8.  Bovine brain-derived growth factor. Purification and characterization of its interaction with responsive cells.

Authors:  J S Huang; S S Huang; M D Kuo
Journal:  J Biol Chem       Date:  1986-09-05       Impact factor: 5.157

9.  Suramin inhibition of growth factor receptor binding and mitogenicity in AKR-2B cells.

Authors:  R J Coffey; E B Leof; G D Shipley; H L Moses
Journal:  J Cell Physiol       Date:  1987-07       Impact factor: 6.384

10.  cDNA sequence of human transforming gene hst and identification of the coding sequence required for transforming activity.

Authors:  M Taira; T Yoshida; K Miyagawa; H Sakamoto; M Terada; T Sugimura
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

View more
  31 in total

Review 1.  Modes of FGF release in vivo and in vitro.

Authors:  P A D'Amore
Journal:  Cancer Metastasis Rev       Date:  1990-11       Impact factor: 9.264

2.  Selective expression of high molecular weight basic fibroblast growth factor confers a unique phenotype to NIH 3T3 cells.

Authors:  N Quarto; D Talarico; R Florkiewicz; D B Rifkin
Journal:  Cell Regul       Date:  1991-09

3.  Preparation of Proper Immunogen by Cloning and Stable Expression of cDNA coding for Human Hematopoietic Stem Cell Marker CD34 in NIH-3T3 Mouse Fibroblast Cell Line.

Authors:  Farzaneh Shafaghat; Hajar Abbasi-Kenarsari; Jafar Majidi; Ali Akbar Movassaghpour; Dariush Shanehbandi; Tohid Kazemi
Journal:  Adv Pharm Bull       Date:  2015-03-05

4.  Fgf-9 is required for angiogenesis and osteogenesis in long bone repair.

Authors:  Björn Behr; Philipp Leucht; Michael T Longaker; Natalina Quarto
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-14       Impact factor: 11.205

5.  Fibroblast growth factor receptor-1 expression is associated with neointimal formation in vitro.

Authors:  S J Daley; A I Gotlieb
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

6.  Differential fibroblast growth factor 8 (FGF8)-mediated autoregulation of its cognate receptors, Fgfr1 and Fgfr3, in neuronal cell lines.

Authors:  Natasha N Mott; Wilson C J Chung; Pei-San Tsai; Toni R Pak
Journal:  PLoS One       Date:  2010-04-12       Impact factor: 3.240

7.  Angiotensin II induces delayed mitogenesis and cellular proliferation in rat aortic smooth muscle cells. Correlation with the expression of specific endogenous growth factors and reversal by suramin.

Authors:  H Weber; D S Taylor; C J Molloy
Journal:  J Clin Invest       Date:  1994-02       Impact factor: 14.808

Review 8.  Autocrine regulation of cell growth and transformation by basic fibroblast growth factor.

Authors:  A Yayon; M Klagsbrun
Journal:  Cancer Metastasis Rev       Date:  1990-11       Impact factor: 9.264

9.  The expression and localization of urokinase-type plasminogen activator and its type 1 inhibitor are regulated by retinoic acid and fibroblast growth factor in human teratocarcinoma cells.

Authors:  J Tienari; T Alanko; E Lehtonen; O Saksela
Journal:  Cell Regul       Date:  1991-04

10.  Basic fibroblast growth factor released by single, isolated cells stimulates their migration in an autocrine manner.

Authors:  P Mignatti; T Morimoto; D B Rifkin
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.